53 hasil

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Josep M. Llovet; Roser Pinyol; Mark Yarchoan dkk.

Nature Reviews Clinical Oncology · 2024 · Inggris · OpenAlex Scopus

Exploring the next generation of antibody–drug conjugates

Kyoji Tsuchikama; Yasuaki Anami; Summer Y.Y. Ha dkk.

Nature Reviews Clinical Oncology · 2024 · Inggris · OpenAlex Scopus

Lung cancer in patients who have never smoked — an emerging disease

Jaclyn LoPiccolo; Alexander Gusev; David C. Christiani dkk.

Nature Reviews Clinical Oncology · 2024 · Inggris · OpenAlex Scopus

Current understanding and management of CAR T cell-associated toxicities

Jennifer N. Brudno; James N. Kochenderfer

Nature Reviews Clinical Oncology · 2024 · Inggris · OpenAlex Scopus

Humanized mouse models for immuno-oncology research

Jane Chuprin; Hannah Buettner; Mina O. Seedhom dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

The roles and implications of RNA m6A modification in cancer

Xiaolan Deng; Ying Qing; David Horne dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Edo Kon; Nitay Ad‐El; Inbal Hazan‐Halevy dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Harnessing mRNA–lipid nanoparticles (LNPs) to treat patients with cancer has been an ongoing research area that started before these versatile nanoparticles were successfully used as COVID-19 vaccines. Currently, efforts are underway to harness this platform for oncology therapeutics, mainly…

Circulating tumour cells for early detection of clinically relevant cancer

Rachel Lawrence; Melissa Watters; Caitlin R. Davies dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Protein degraders enter the clinic — a new approach to cancer therapy

Deborah Chirnomas; Keith R. Hornberger; Craig M. Crews

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Long-term outcomes following CAR T cell therapy: what we know so far

Kathryn M. Cappell; James N. Kochenderfer

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Optimizing the safety of antibody–drug conjugates for patients with solid tumours

Paolo Tarantino; Biagio Ricciuti; Shan Pradhan dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

Maryam B. Lustberg; Nicole M. Kuderer; Aakash Desai dkk.

Nature Reviews Clinical Oncology · 2023 · Inggris · OpenAlex Scopus

Despite the importance of chemotherapy-associated adverse events in oncology practice and the broad range of interventions available to mitigate them, limited systematic efforts have been made to identify, critically appraise and summarize the totality of evidence on the effectiveness of these…

Senescence and cancer — role and therapeutic opportunities

Clemens A. Schmitt; Boshi Wang; Marco Demaria

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

Radiotheranostics in oncology: current challenges and emerging opportunities

Lisa Bodei; Ken Herrmann; Heiko Schöder dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

The current state of the art and future trends in RAS-targeted cancer therapies

Salman R. Punekar; Vamsidhar Velcheti; Benjamin G. Neel dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Christian Flugel; Robbie G. Majzner; Giedre Krenciute dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

Is early-onset cancer an emerging global epidemic? Current evidence and future implications

Tomotaka Ugai; Naoko Sasamoto; Hwa‐Young Lee dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management

Alissa J. Cooper; Lecia V. Sequist; Jessica J. Lin

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

Matt Lechner; Jacklyn Liu; Liam Masterson dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus

Immune-checkpoint inhibitors: long-term implications of toxicity

Douglas B. Johnson; Caroline A. Nebhan; Javid J. Moslehi dkk.

Nature Reviews Clinical Oncology · 2022 · Inggris · OpenAlex Scopus